Physician

Peter S.e. Nechay, MD

According to 2025 Medicare claims, Peter Nechay, MD (NPI: 1831168525) practices cardiology in the Kokomo, IN market, with the plurality of this provider's patient population coming from Howard, IN. This provider's primary affiliated billing organization is ST. VINCENT MEDICAL GROUP, INC. (NPI: 1144513375; TIN: 272039417) and primary practice location at 46902-6079. Nechay is affiliated with the Ascension Care Management (ACO ID: A2600), CHSPSC ACO 2, LLC (ACO ID: A3664), and Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), participating under the MSSP model.

Nechay's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 917 traditional Medicare patients, billed 1,625 HCPCS/CPT codes, and received $96,787 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,393 prescription claims across 1,079 beneficiaries totaling $1,893,259 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 25 claims. Open Payments data shows 1 records totaling $22. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $174,110 to $96,787. In contrast, Part D prescription costs have moved sharply higher in recent years, from $475,612 to $1,893,259. For DME billing, this smaller-volume category fell sharply in recent years, from $4,782 to $1,426.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,760	4,270	$174,110
2016	1,674	4,141	$165,032
2017	1,456	3,150	$134,946
2018	1,409	2,777	$113,482
2019	1,434	2,655	$114,443
2020	1,170	2,109	$89,016
2021	1,161	2,144	$121,179
2022	1,128	2,130	$120,354
2023	971	1,750	$110,415
2024	917	1,625	$96,787

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	833	6,490	$475,612
2016	977	7,738	$628,803
2017	939	7,680	$690,518
2018	921	7,596	$824,001
2019	984	7,566	$1,041,790
2020	892	7,394	$1,133,000
2021	859	7,166	$1,186,092
2022	1,140	8,294	$1,481,029
2023	1,093	9,136	$1,807,733
2024	1,079	9,393	$1,893,259

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	41	$4,097
2016	N/R	105	$4,649
2017	N/R	70	$2,096
2018	N/R	40	$1,235
2019	N/R	15	$854
2020	N/R	42	$2,325
2021	N/R	N/R	N/R
2022	N/R	25	$1,393
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	545	873	$79
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	53	53	$51
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	174	174	$47
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	71	71	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	126	150	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	833	57,610	$1,081,956
Xarelto	Rivaroxaban	135	10,000	$182,142
Entresto	Sacubitril/Valsartan	117	7,766	$168,830
Multaq	Dronedarone Hcl	59	4,435	$114,548
Repatha Sureclick	Evolocumab	95	5,710	$110,025

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$22	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Peter S.e. Nechay, MD?

Tedicare shows public-source Medicare data for Peter S.e. Nechay, MD (NPI 1831168525), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter S.e. Nechay, MD have ACO affiliation data?

Peter S.e. Nechay, MD is shown with ACO affiliation data for Ascension Care Management (MSSP, ACO ID A2600), CHSPSC ACO 2, LLC (MSSP, ACO ID A3664), and Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403).

What billing organization is linked to Peter S.e. Nechay, MD?

Peter S.e. Nechay, MD is linked to ST. VINCENT MEDICAL GROUP, INC. (billing NPI 1144513375) in the available physician profile data.

Does Peter S.e. Nechay, MD have Open Payments data?

Peter S.e. Nechay, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.